Chronic Respiratory Disease — Shedding Light on a Forgotten Workforce: Loved Ones of People With Chronic Respiratory Diseases
Citation(s)
Apostolo JLA, Paiva DDS, Silva RCGD, Santos EJFD, Schultz TJ Adaptation and validation into Portuguese language of the six-item cognitive impairment test (6CIT). Aging Ment Health. 2018 Sep;22(9):1184-1189. doi: 10.1080/13607863.2017.1348473. Epub 2017 Jul 25.
Cruz J, Marques A, Figueiredo D Impacts of COPD on family carers and supportive interventions: a narrative review. Health Soc Care Community. 2017 Jan;25(1):11-25. doi: 10.1111/hsc.12292. Epub 2015 Oct 26.
Ewing G, Grande G; National Association for Hospice at Home Development of a Carer Support Needs Assessment Tool (CSNAT) for end-of-life care practice at home: a qualitative study. Palliat Med. 2013 Mar;27(3):244-56. doi: 10.1177/0269216312440607. Epub 2012 Mar 26.
GBD 2019 Chronic Respiratory Diseases Collaborators Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023 May;59:101936. doi: 10.1016/j.eclinm.2023.101936.
Kaptain RJ, Helle T, Patomella AH, Weinreich UM, Kottorp A New Insights into Activities of Daily Living Performance in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2021 Jan 7;16:1-12. doi: 10.2147/COPD.S264365. eCollection 2021.
Kong YL, Anis-Syakira J, Jawahir S, R'ong Tan Y, Rahman NHA, Tan EH Factors associated with informal caregiving and its effects on health, work, and social activities of adult informal caregivers in Malaysia: findings from the National Health and Morbidity Survey 2019. BMC Public Health. 2021 Jun 1;21(1):1033. doi: 10.1186/s12889-021-11022-1.
Kusier AO, Folker AP The Satisfaction with Life Scale: Philosophical Foundation and Practical Limitations. Health Care Anal. 2021 Mar;29(1):21-38. doi: 10.1007/s10728-020-00420-y. Epub 2021 Jan 2.
Lee Y, Li L Evaluating the Positive Experience of Caregiving: A Systematic Review of the Positive Aspects of Caregiving Scale. Gerontologist. 2022 Oct 19;62(9):e493-e507. doi: 10.1093/geront/gnab092.
Nakazawa A, Cox NS, Holland AE Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis. 2017 Feb;11(2):115-128. doi: 10.1177/1753465816676048. Epub 2016 Nov 15.
Pena-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega A, Miravitlles M Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD). BMC Health Serv Res. 2015 Mar 15;15:101. doi: 10.1186/s12913-015-0759-6.
Trivedi RB, Bryson CL, Udris E, Au DH The influence of informal caregivers on adherence in COPD patients. Ann Behav Med. 2012 Aug;44(1):66-72. doi: 10.1007/s12160-012-9355-8.
Zarit SH, Reever KE, Bach-Peterson J Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980 Dec;20(6):649-55. doi: 10.1093/geront/20.6.649. No abstract available.
Shedding Light on a Forgotten Workforce: Loved Ones of People With Chronic Respiratory Diseases
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.